Ultra-high dose methylcobalamin (E0302) prolongs survival of ALS: Report of 7 years’ randomised double-blind, phase 3 clinical trial (ClinicalTrials.gov NCT00444613) (P7.060)
用户6-0Gp5PnQYk4
19小时前
14
10
已关闭
DOI: 10.1212/wnl.84.14_supplement.p7.060
文献链接: https://www.neurology.org/doi/10.1212/WNL.84.14_supplement.P7.060
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Ryuji Kaji; Shigeki Kuzuhara; Yasuo Iwasaki; Koichi Okamoto; Masanori Nakagawa; Takashi Imai; Takao Takase; Hiroki Shimizu; Kunio Tashiro